Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05402033 · ClinicalTrials.gov registry record

Cancer Clinical Trials Financial Reimbursement Program

A clinical trial of Cancer Clinical Trials, sponsored by University of Texas Southwestern Medical Center.

Recruiting
Registry status
1,200
Enrollment target
1
Study location

NCT05402033 is a study of Cancer Clinical Trials that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 1,200 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05402033, a study of Cancer Clinical Trials, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.

RECRUITING
Registry status
1,200 participants
Enrollment target
1
Study location

Study Summary

To implement a Financial Reimbursement and Outreach Program at clinical sites within the Harold C. Simmons Comprehensive Cancer Center; and evaluate the impact of the program on clinical trial enrollment and demographics, as well as facilitators of and barriers to program participation.

Conditions Studied

Interventions

  • BEHAVIORAL Survey / Interview Group

Study Locations (1)

Texas

  • University of Texas Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 1,200 participants
Start Date 2022-07-12
Est. Completion 2027-06-01

What the Registry Record Tells You About NCT05402033

The ClinicalTrials.gov registry entry for NCT05402033 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer Clinical Trials appearing as the primary indexed condition, and to 1 intervention - of which Survey / Interview Group is the first listed.

NCT05402033 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05402033 about?

NCT05402033 is a clinical study titled "Cancer Clinical Trials Financial Reimbursement Program". To implement a Financial Reimbursement and Outreach Program at clinical sites within the Harold C. Simmons Comprehensive Cancer Center; and evaluate the impact of the program on clinical trial enrollment and demographics, as well as facilitators of and barriers to program participation.

What is the current status of trial NCT05402033?

This trial is currently recruiting. The enrollment target is 1,200 participants. The study started on 2022-07-12. Estimated completion is 2027-06-01.

What conditions does trial NCT05402033 study?

This clinical trial studies the following conditions: Cancer Clinical Trials.

What interventions are being tested in trial NCT05402033?

The interventions under investigation include: Survey / Interview Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT05402033?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05402033 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer Clinical Trials

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.